BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21533545)

  • 1. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.
    Yu J; Liu P; Cui X; Sui Y; Ji G; Guan R; Sun D; Ji W; Liu F; Liu A; Zhao Y; Yu Y; Jin Y; Bai J; Geng J; Xue Y; Qi J; Lee KY; Fu S
    Mol Cells; 2011 Jul; 32(1):47-55. PubMed ID: 21533545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.
    Ma H; Weng D; Chen Y; Huang W; Pan K; Wang H; Sun J; Wang Q; Zhou Z; Wang H; Xia J
    Mol Cancer; 2010 Jul; 9():190. PubMed ID: 20626849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
    Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
    Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of tumor suppressor gene HIC1 in gastric cancer is reversed via small activating RNAs.
    Pan S; Wang Z; Chen Y; Chen X; Ji J; Zhang J; Li J; Cai Q; Liu B; Zhu Z; Yu Y
    Gene; 2013 Sep; 527(1):102-8. PubMed ID: 23769968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promoter methylation drives down-regulation mode of HIC1 in gastric cancer, its molecular characteristics and downstream functional pathways.
    Zhao T; Yang T; Zhang J; Hao H; Wang D; Afirifa J; Cai M; Cui X; Bai J; Fu S; Yu J
    Gene; 2022 May; 824():146380. PubMed ID: 35276239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
    Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
    Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
    Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
    Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
    Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
    Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
    Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma.
    Dong Z; Zhang G; Lu J; Guo Y; Liang J; Shen S; Guo W
    Dig Dis Sci; 2023 Apr; 68(4):1316-1331. PubMed ID: 36002674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
    Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
    Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses.
    Lee JH; Byun DS; Lee MG; Ryu BK; Kang MJ; Chae KS; Lee KY; Kim HJ; Park H; Chi SG
    Int J Cancer; 2008 Apr; 122(7):1573-84. PubMed ID: 18059034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer.
    Wang H; Xu M; Cui X; Liu Y; Zhang Y; Sui Y; Wang D; Peng L; Wang D; Yu J
    Sci Rep; 2016 Feb; 6():21755. PubMed ID: 26923709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.
    Kundu J; Wahab SM; Kundu JK; Choi YL; Erkin OC; Lee HS; Park SG; Shin YK
    Int J Oncol; 2012 Sep; 41(3):839-48. PubMed ID: 22710759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.